Insider Transactions in Q3 2021 at Ptc Therapeutics, Inc. (PTCT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
3,363
-6.5%
|
$151,335
$45.01 P/Share
|
|
Sep 02
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,363
+6.1%
|
$60,534
$18.01 P/Share
|
|
Aug 13
2021
|
Stephanie Okey |
SELL
Open market or private sale
|
Direct |
1,650
-63.15%
|
$66,000
$40.06 P/Share
|
|
Jul 09
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
1,429
-0.73%
|
$64,305
$45.0 P/Share
|
|
Jul 09
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,429
+0.73%
|
$25,722
$18.01 P/Share
|
|
Jul 08
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
7,805
-2.62%
|
$351,225
$45.23 P/Share
|
|
Jul 08
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,805
+2.55%
|
$117,075
$15.75 P/Share
|